J. Bufill

发表

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

J. Szustakowski, P. Stephens, C. Rudin, 2018, Cancer discovery.

Hereditary Desmoid Disease in a Family with a Germline Alu I Repeat Mutation of the APC Gene

S. Powell, N. Lindor, R. Honchel, 1999, Human Heredity.

Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53

Menggang Yu, J. Leblanc, H. Cárdenes, 2012, Cancer Chemotherapy and Pharmacology.

A Phase II Study of Single Agent Gemcitabine in Relapsed or Refractory Follicular or Small Lymphocytic Non-Hodgkin Lymphomas: A Hoosier Oncology Group Study

Sin-Ho Jung, K. Ganjoo, L. Cripe, 2005, American journal of clinical oncology.

Phenotypic Expression of Disease in Families That Have Mutations in the 5 Region of the Adenomatous Polyposis Coli Gene

G. Petersen, S. Hamilton, M. Cayouette, 1997, Annals of Internal Medicine.

Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling

P. Stephens, S. Ou, B. Halmos, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Author Summary: Abstract and Brief Discussion

Menggang Yu, J. Picus, R. Ramasubbaiah, 2011 .

Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.

Menggang Yu, J. Picus, R. Ramasubbaiah, 2012, The oncologist.

Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.

Mark Rosenzweig, Joel Greshock, Doron Lipson, 2015, Cancer discovery.

Pityrosporum folliculitis after bone marrow transplantation. Clinical observations in five patients.

P. Ritch, J. Bufill, L. Lum, 1988, Annals of internal medicine.

Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location.

J. Bufill, J A Bufill, 1990, Annals of internal medicine.

Diverse EGFR Exon 20 Insertions and Co‐Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC

J. McPherson, P. Stephens, J. Riess, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica

A. Panlilio, A. Grindon, M. Arduino, 1990, Transfusion.

Yersinia enterocolitica serotype O:3 sepsis after blood transfusion.

P. Ritch, J. Bufill, 1989, The New England journal of medicine.

Intra‐arterial Chemotherapy for Palliation of Fungating Breast Cancer: A Case Report and Review of the Literature

J. Bufill, R. Neff, W. Grace, 1994, American journal of clinical oncology.

Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy.

J. Gregg, J. Hughes, V. Miller, 2019, Journal of gastrointestinal oncology.

Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)

T. Whelan, G. Sledge, D. Cella, 2018, Breast Cancer Research and Treatment.

Amyl nitrite-induced hemolytic anemia.

J. Bufill, A. Pisciotta, J. Brandes, 1989, The American journal of medicine.